Navigation Links
Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration
Date:3/7/2012

MOUNTAIN VIEW, Calif., March 7, 2012 /PRNewswire/ -- Today, Cobalt Technologies, a leading developer of next generation n-butanol, announced the achievement of major progress toward commercial scale by successfully demonstrating its biomass pretreatment process. Cobalt in cooperation with ANDRITZ, a globally leading supplier of technologies, equipment and plants for the pulp and paper industry, tested its dilute acid hydrolysis pretreatment process, the first step of Cobalt's process for converting sugars into n-butanol for use as a renewable chemical or fuel.

"Demonstrating our high-yield pretreatment process is a key milestone for Cobalt as we prove that our n-butanol technology will efficiently work at commercial scale and at an attractive low cost," said Bob Mayer, CEO of Cobalt Technologies. "This is a very exciting time at Cobalt as we continue our path to commercialization and deepen our relationships with key partners."

Cobalt conducted the testing in the ANDRITZ pulp and paper mill demonstration facility in Springfield, OH, which is specifically designed to validate new processes before commercial-scale implementation. Cobalt's dilute acid hydrolysis pretreatment process, which extracts sugars from ligno-cellulosic biomass, was validated on woody biomass, bagasse and agricultural residues.

"We have extensive experience and expertise in process know-how and technologies for biomass processing and were eager to work with Cobalt on this project," said Bertil Stromberg, vice president of biofuel for ANDRITZ.

Using ANDRITZ's proven pulp processing equipment, Cobalt tested its pre-treatment process on both a batch and continuous basis, proving both its flexibility and efficiency for potential customers. These runs, while processing up to 20 bone-dry tons of biomass per day, successfully extracted sugars from the biomass without the use of enzymes t
'/>"/>

SOURCE Cobalt Technologies
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...
(Date:5/22/2013)... N.H. , May 22, 2013  Superior ... the Year 2013" by Business NH Magazine.  For ... Granite State organizations that distinguish themselves with extraordinary ... very proud to receive this honor," said ... Controls.  "As with any recognition, this award is ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Genedata, ... industrial biotechnology, drug discovery, and life science research, ... Selector ™ as its bioinformatics platform for ... organisms. Genedata will provide AB Enzymes, one of ... a hosted solution of Genedata Selector accompanied by ...
(Date:5/22/2013)... 22, 2013 AudioNotch ... for tinnitus treatment. AudioNotch is pleased to announce ... clinic locations in both British Columbia and Alberta, ... and hearing services. AudioNotch's tinnitus treatment program is ... entering a Destination Hearing clinic, patients have the ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2
... on QuatRx clinical development programs, including review of positive results ... ... ANN ARBOR, Mich., Jan. 4 QuatRx Pharmaceuticals Company,today announced that ... presenter at the 26th Annual JP Morgan Healthcare,Conference on Tuesday, January ...
... the Company has been invited and has accepted to ... January 7-10, 2008 at,the Westin St. Francis Hotel in ... Chief Executive Officer will provide an,overview of the Company ... About JPMorgan 26th Annual Healthcare Conference, JPMorgan,s premier ...
... safety and efficacy in treatment of multi-drug ... resistant infections ... or the "Company"), a biopharmaceutical company focused on the,development of novel ... the first patients in two,separate Phase 2 clinical trials. The studies ...
Cached Biology Technology:QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 2Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 2Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 3
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
(Date:5/21/2013)... scientists have developed many devices that can reopen clogged ... effective, each of these treatments has drawbacks, including the ... MIT analyzes the potential usefulness of a new treatment ... stents, but may pose fewer risks. With this new ... only a brief period, during which it releases a ...
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... Montral, June 23, 2009 On June 18, the ... $9.16 million for the creation of a national technology ... platform, headed by Dr. Benoit Coulombe from the Institut ... provide Canadian researchers with new state-of-the-art equipment in proteomics, ...
... 2009) University of Minnesota Medical School researchers have discovered an ... to treat those infected by a parasitic flatworm. ... The Schistosomasis parasite infects about 200 million people in ... where people become infected simply by bathing, drinking, or cooking water ...
... whips up more powerful and frequent hurricanes and storms, the ... breed and recover from damage. That,s one of the ... corals in the wake of large climate-driven bleaching and storm ... the regrowth of young corals drops sharply in ...
Cached Biology News:A Canada-wide technology platform for mapping the human interactome 2U of M study finds new insight on therapy for a devastating parasitic disease 2Coral face 'a stormy future' 2
... The IEC Centra CL3 series ... in typical research and clinical applications ... broad accessory package includes quick connect ... An advanced yet intuitive interface allows ...
PP2B-Abeta (C-20)...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... H2OBIT™ is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... A robotic arm rapidly transfers a ... in temperature ramping times that are considerably faster ...
Biology Products: